Address: N. Querido 2285 – (B1065CYC) Munro, Pcia. de Bs As.,Argentina
Tel: 4756-5436 #294
Web: http://www.denverfarma.com.ar/Home.asp
A young and dynamic Argentinean company, Denver Farma has recently invested in a state-of-the-art production facility, which it hopes to use to propel itself into a key position within the Argentinean pharmaceutical industry. Denver Farma focuses mainly on generic products for both national consumption and for export, but was the first company in Argentina to produce recombinant human insulin in Argentina, for Argentinians.
Denver Farma is committed to improving knowledge of diabetes in Argentina, as well as access to quality and affordable insulin. It founded the Centre for Diabetes Care in order to address this problem, and is constantly innovating in order to provide patients with the best medicines, both at home and abroad.
Anesthesia, Antiparasitic, Antisepsis, Anxiolytic, Cardiology, Cold & Flu drugs, Contrast Media, Dermatology, Diabetology, Ear drops, Gastroenterology, Gynecology, Infectious Diseases, Neurology, Nutrition, Ophthalmology, Pain / Inflammation, Psychiatry
The president of Denver Farma explains how crucial exports are for his company, especially to countries like Brazil where the market participation of local companies is small, and multinational companies…
Could you give us an overview of the generics sector in Argentina as it stands at the moment? The generics market in Argentina was started immediately after the regulation regarding…
A roundup of some of the latest stories coming out of Latin American pharma and healthcare, including Merck’s new distribution centre in Brazil; the region’s record dengue surge; Roemmers Laboratory’s…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Mariana Abdala of Crystal Research outlines the vast room for improvement in Latin America’s clinical trial output, the region’s…
Japanese-headquartered Takeda has been undergoing a transformation in recent years, becoming the global leader in rare diseases with the acquisition of Shire in 2018 and divesting ‘non-core’ assets in OTC…
Argentinian generics manufacturer Grupo Roemmers – which celebrated its 100-year anniversary in 2021 – has expanded steadily across the Latin America and Caribbean region since the mid-1970s with a successful…
While Bayer’s recent history has been dominated by the controversial Monsanto acquisition, the German firm will be hoping for a more straightforward next few years with a new leadership team…
Argentinian generics manufacturer Grupo Roemmers – which celebrated its 100-year anniversary in 2021 – has expanded steadily across the Latin America and Caribbean region since the mid-1970s with a successful…
Axios International has been designing and implementing access to healthcare solutions in collaboration with the pharmaceutical industry and other healthcare players across Latin America (LatAm), Europe, the Middle East, Africa,…
Maria Gabriela Pittis, Head of SAM (South Cone, Andean Region, Mexico & Central America and Caribbean) at Takeda, outlines the company’s significant presence in the cluster, its double digit growth…
Florencia Davel, head of LatAm operations for Bristol Myers Squibb (BMS) looks back on a successful four years in position, shaping the regional organisation into a true biopharma player in…
The Head of Viatris Latin America, Patrick Doyle, spoke to PharmaBoardroom about setting up the two-year old company’s Latam affiliate during the pandemic, the decision to focus on specific therapeutic…
Boehringer Ingelheim’s managing director for South America, Dirk van Niekerk, provides an overview of the healthcare climate in South America, the challenges tied to political and economic instability, future opportunities…
Dr Guillermo Chantada, incoming president-elect of the International Society of Paediatric Oncology (SIOP) highlights the progress of paediatric oncology in Latin America and gives a call to arms to the…
See our Cookie Privacy Policy Here
